Apogee Therapeutics, Inc. (APGE)

NGM – Real vaqt narxi. Valyuta: USD

134.57

-0.12 (-0.09%)

Bozor ochiq: Aug 12, 2026, 11:36 AM EDT

134.70

+0.01 (0.01%)

Oldingi bozordan keyin: Aug 11, 2026, 7:34 PM EDT

10.08.2026

Apogee Reports Second Quarter 2026 Financial Results and Recent Corporate and Pipeline Updates

AbbVie to acquire Apogee for $135.11 per share in cash for total equity value of approximately $10.9 billion, positioning differentiated immunology portfolio to reach more patients worldwide Positive 16-week Phase 2 APEX Part B induction dose optimization results support planned advancement of zumilokibart into Phase 3 development in moderate-to-severe atopic dermatitis this year SAN FRANCISCO and BOSTON, Aug. 10, 2026 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc. (Nasdaq: APGE), a clinical-stage biotechnology company advancing optimized, novel biologics with the potential for best-in-class profiles in the largest inflammatory and immunology (I&I) markets, today reported second quarter 2026 financial results, recent corporate updates and pipeline progress. "The second quarter marked a transformational period for Apogee," said Michael Henderson, M.D.

Videolar

No Data

There is no data to display

Press-relizlar

10.08.2026

Apogee Therapeutics, Inc. (APGE)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Apogee Therapeutics, Inc. (APGE)

Apogee Reports Second Quarter 2026 Financial Results and Recent Corporate and Pipeline Updates

Videolar

No Data

Press-relizlar

Apogee Reports Second Quarter 2026 Financial Results and Recent Corporate and Pipeline Updates

Apogee Reports Second Quarter 2026 Financial Results and Recent Corporate and Pipeline Updates

Videolar

No Data

Press-relizlar

Apogee Reports Second Quarter 2026 Financial Results and Recent Corporate and Pipeline Updates

Search stocks

Apogee Therapeutics, Inc. (APGE)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Apogee Therapeutics, Inc. (APGE)

Apogee Reports Second Quarter 2026 Financial Results and Recent Corporate and Pipeline Updates

Videolar

No Data

Press-relizlar

Apogee Reports Second Quarter 2026 Financial Results and Recent Corporate and Pipeline Updates

Apogee Reports Second Quarter 2026 Financial Results and Recent Corporate and Pipeline Updates

Videolar

No Data

Press-relizlar

Apogee Reports Second Quarter 2026 Financial Results and Recent Corporate and Pipeline Updates